Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
ARKGvsGNOMETF Comparison
ARK Genomic Revolution ETF (ARKG) and Global X Genomics & Biotechnology ETF - USD (GNOM) belong to the same industry segment: BioTech & Genomics. ARKG's top 3 sector exposures are Health Care and Information Technology. In contrast, GNOM's top sector exposures are Health Care ARKG is more expensive with a Total Expense Ratio (TER) of 0.75%, versus 0.5% for GNOM. ARKG is down -5.11% year-to-date (YTD) with -$10M in YTD flows. GNOM performs better with -4.83% YTD performance, and -$2M in YTD flows. Run a side-by-side ETF comparison of ARKG and GNOM below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
ARKG vs GNOM performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | ARKG GNOM | -3.62%-5.57% | -10.23%-6.28% | -5.11%-4.83% | +23.23%+25.75% | -2.84%-9.66% | -70.08%-54.21% |
| Flows | ARKG GNOM | -$50M- | -$85M-$4M | -$10M-$2M | -$210M-$19M | -$627M-$115M | -$2.79B+$8M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | ARKG GNOM | +39.15%+24.33% | +44.62%+30.10% | +42.26%+28.55% | +45.19%+33.48% |
| Max drawdown | ARKG GNOM | -19.50%-14.34% | -23.94%-22.14% | -51.98%-46.50% | -80.33%-72.17% |
| Max drawdown duration | ARKG GNOM | 48d50d | 77d113d | 966d1033d | 1822d1716d |
ARKG | GNOM | |
Last sale 3/13/2026 at 1:30 PM | $26.36 | $43.24 |
| Previous close 03/12/2026 | $26.17 | $43.61 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
ARKG | GNOM | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
ARKG | GNOM | |
|---|---|---|
| Last price | $26.36 | $43.24 |
| 1D performance | +0.73% | -0.84% |
| AuM | $1.11 B | $47.44 M |
| E/R | 0.75% | 0.5% |
ARKG | GNOM | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Ark Investment | Global X |
| Benchmark | - | Solactive Genomics Index |
| N° of holdings | 30 | 46 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | April 2, 2019 | April 5, 2019 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Top 15 holdings
How have the ARKG and GNOM ETFs performed in 2026?
As of March 11, 2026, ARKG is down -5.11% year-to-date (YTD), while GNOM has lost -4.83%. That puts GNOM better performer ahead so far this year.
Which ETF is attracting more investor money: ARKG or GNOM?
Year-to-date, the ARKG ETF saw -$10M in flows, compared to -$2M for GNOM.
Which ETF is more volatile: ARKG or GNOM?
Over the past year, ARKG had a volatility of 44.62%, while GNOM experienced 30.1%.
Which ETF is bigger: ARKG or GNOM?
As of March 11, 2026, ARKG holds $1.11 B in assets under management (AUM), while GNOM manages $47.44 M.
What sectors do the ARKG and GNOM ETFs invest in?
ARKG leans toward sectors like Health Care. Meanwhile, GNOM focuses on Health Care.
What are the top holdings of the ARKG ETF and GNOM ETF?
ARKG top holdings include CRISPR THERAPEUTICS, PERSONALIS INC and GUARDANT HEALTH INC. GNOM holds in its top three: MODERNA INC, ARROWHEAD PHARMACEUTICALS INC and US74006W2070.
Which ETF is more diversified: ARKG or GNOM?
ARKG holds 30 securities with 63.79% of its assets in the top 15. GNOM has 48 securities and a top 15 weight of 63.95%.
Active Trader Report: Use of Leveraged & Inverse ETFs Way Up
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
